APR 24, 2020 1:10 AM PDT

Combination Immunotherapy Allows Immune Cells To Target Tumors

WRITTEN BY: Nouran Amin

A drug combination of immunotherapeutic agents encourages immune cells to devour cancer cells according to findings published in Nature Communications.

By blocking the CD47 protein—a marker on cancer cells that prevents them from being tracked by immune cells—tumors can be vulnerable to immune surveillance.

Learn more about cancer and the immune system:

“In recent years, researchers have had considerable success in harnessing the immune system to fight some cancers, developing several drugs that have vastly extended survival,” explains study leader Wen Jiang, M.D., Ph.D., assistant professor of radiation oncology at UT Southwestern Medical Center.

Researchers began the inhibition process by administering the temozolomide (TMZ) therapeutic—a drug that promotes stress responses in cancer cells making the immune system more likely to ‘capture’ them.

“Although this drug also increased phagocyte consumption of the cancer cells, these results were also lackluster,”says Jiang, also a member of UT Southwestern's Harold C. Simmons Comprehensive Cancer Center.

"If a new therapy extends survival by even one to two months, it's considered a blockbuster drug," Jiang says. "Here, we're talking potentially about a significant proportion of patients who could be cured. Bridging the innate and adaptive immune systems could prove to be a major advance for GBM."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 11, 2020
Drug Discovery & Development
Scientists Discover Key Gene Behind Antibiotic Resistance
AUG 11, 2020
Scientists Discover Key Gene Behind Antibiotic Resistance
Scientists from Oxford University have shown that a single gene can make some strains of Staphylococcus aureus (the bact ...
AUG 12, 2020
Drug Discovery & Development
Fast Tracking Drug Therapies
AUG 12, 2020
Fast Tracking Drug Therapies
Fast-tracking drugs in a safe and effective way can eventually save the lives of many from life-threatening diseases. Ne ...
AUG 22, 2020
Drug Discovery & Development
New Class of Antibiotics Could Treat UTIs
AUG 22, 2020
New Class of Antibiotics Could Treat UTIs
At 11 million cases annually, urinary tract infections (UTIs) are the most common outpatient infections in the U.S., Sci ...
SEP 08, 2020
Drug Discovery & Development
New Drug Boosts Bone Growth in Children with Dwarfism
SEP 08, 2020
New Drug Boosts Bone Growth in Children with Dwarfism
A Phase III global clinical trial by the Murdoch Children’s Research Institute (MCRI) has found that a new drug, k ...
OCT 20, 2020
Cannabis Sciences
Should Cannabis Doses Be Standardized?
OCT 20, 2020
Should Cannabis Doses Be Standardized?
Should cannabis and its compounds such as tetrahydrocannabinol (THC), the psychoactive compound in cannabis, come in sta ...
OCT 06, 2020
Drug Discovery & Development
Drug For A Severe E. Coli Infection
OCT 06, 2020
Drug For A Severe E. Coli Infection
Escherichia coli, known as E. coli, is a popular bacterium associated with food poisoning and depending on the strain ca ...
Loading Comments...